| ASSET | DATE | % RETURN |
|---|---|---|
Immunovant (IMVT) | 5/20/2026 | 16.82% |
Navitas Semiconductor (NVTS) | 5/20/2026 | 14.52% |
RXO (RXO) | 5/20/2026 | 12.24% |
Abcellera Biologics (ABCL) | 5/20/2026 | 11.46% |
Enphase Energy (ENPH) | 5/20/2026 | 10.91% |
Viridian Therapeutics (VRDN) | 5/20/2026 | 10.19% |
Alaska Air (ALK) | 5/20/2026 | 9.42% |
Relay Therapeutics (RLAY) | 5/20/2026 | 9.14% |
Perpetua Resources (PPTA) | 5/20/2026 | 9.12% |
CorVel (CRVL) | 5/20/2026 | 9.08% |
Seabridge Gold (SA) | 5/20/2026 | 8.96% |
Compass (COMP) | 5/20/2026 | 8.88% |
USA Rare Earth (USAR) | 5/20/2026 | 8.77% |
Oklo (OKLO) | 5/20/2026 | 8.72% |
RH (RH) | 5/20/2026 | 8.7% |
Dyne Therapeutics (DYN) | 5/20/2026 | 8.53% |
Sellas Life Sciences (SLS) | 5/20/2026 | 8.33% |
Immunome (IMNM) | 5/20/2026 | 7.97% |
Builders FirstSource (BLDR) | 5/20/2026 | 7.27% |
Veracyte (VCYT) | 5/20/2026 | 7.19% |
Victoria's Secret (VSXY) | 5/20/2026 | 7.14% |
Erasca (ERAS) | 5/20/2026 | 7.13% |
Gap (GAP) | 5/20/2026 | 7.11% |
Norwegian Cruise Line (NCLH) | 5/20/2026 | 7.01% |
Celcuity LLC (CELC) | 5/20/2026 | 7.01% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.